Martyn Gibson

Martyn has over 25 years in financial management and strategic planning for high growth businesses in industrial, pharmaceutical and consumer goods industries.

Martyn joined Metrasens in 2020 following 3 years as Chief Financial Officer at Symetria Health. Prior to Symetria, he spent 12 years at Reckitt Benkiser Pharmaceuticals supporting the commercialization and manufacture of Suboxone® and other related market leading pharmaceuticals. His roles included Global Head of Finance, Head of Finance (US), and Global Strategic Planning and Analytics Director. Martyn has fellowship designation from the Association of Chartered Certified Accountants (ACCA).